Mary Ann Liebert to launch Disruptive Science and Technology

NewsGuard 100/100 Score

Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com/) announces the launch of Disruptive Science and Technology, a highly innovative, bimonthly peer-reviewed journal that seeks to publish game-changing research that has the potential to significantly improve human health, well-being, and productivity. The Journal will present new and innovative results, essential data, cutting-edge discoveries, thorough syntheses and analyses, and publish out-of-the-box concepts that will improve the way we live. Complete information on the Journal is available online at http://www.liebertpub.com/dst.

"Although much has been written about disruptive innovation and the business practices that can harness radical new ideas to change the course of history, there is no venue that has been designed to accelerate the pace at which enabling science and engineering will be developed to innovate disruptively," says Editor-in-Chief Alan J. Russell, PhD, Distinguished University Professor and Founding Director, McGowan Institute for Regenerative Medicine, University of Pittsburgh and UPMC. "This journal will provide a custom-designed forum for the publication of breakthrough science and engineering that has the capacity to dynamically improve our society."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses